Cancer - Vincerx Pharam, Inc.
Cancer
Status:
Active, open to accrualClinicalTrials.gov:
NCT05712889An open-label, multicenter Phase 1 study to characterize safety, tolerability, preliminary antitumor activity and pharmacokinetics of VIP236 monotherapy in subjects with advanced cancer